Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$132,255 Mln
P/E Ratio
43.65
P/B Ratio
6.28
Industry P/E
--
Debt to Equity
0.07
ROE
0.15 %
ROCE
11.16 %
Div. Yield
0.99 %
Book Value
53.51
EPS
7.76
CFO
$23,728.00 Mln
EBITDA
$34,003.00 Mln
Net Profit
$19,373.00 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Stryker (SYK)
| -0.82 | -3.77 | -8.55 | 8.98 | 12.88 | 14.44 | 13.99 |
|
BSE Sensex*
| 2.13 | 3.91 | 4.44 | 8.38 | 11.79 | 20.19 | 11.16 |
|
S&P 100
| -10.76 | -5.59 | -12.69 | 9.46 | 10.08 | 15.03 | 10.89 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Stryker (SYK)
| 20.05 | 22.48 | -8.57 | 10.22 | 18.17 | 35.33 | 2.42 |
|
S&P 100
| 29.04 | 30.83 | -22.12 | 27.55 | 19.30 | 29.47 | -5.82 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 129.84 | 225,270.82 | 17 | 31.07 | |
| 98.92 | 138,411.38 | 74.86 | 9.03 | |
| 487.93 | 167,787.35 | 72.95 | 15.62 | |
| 431.64 | 161,377.88 | 25.5 | 13.16 |
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems,... endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan. Address: 1941 Stryker Way, Portage, MI, United States, 49002 Read more
Chairman, CEO & President
Mr. Kevin A. Lobo
Chairman, CEO & President
Mr. Kevin A. Lobo
Headquarters
Portage, MI
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Stryker Corporation (SYK) stood at $ 42,971 Mln as on 31-Dec-24
The share price of Stryker Corporation (SYK) is $357.11 (NYSE) as of 23-Apr-2025 16:14 EDT. Stryker Corporation (SYK) has given a return of 12.88% in the last 3 years.
Stryker Corporation (SYK) has a market capitalisation of $ 132,255 Mln as on 22-Apr-2025. As per Value Research classification, it is a Large Cap company.
The P/E ratio of Stryker Corporation (SYK) is 43.65 times as on 22-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Stryker Corporation (SYK) and enter the required number of quantities and click on buy to purchase the shares of Stryker Corporation (SYK).
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan. Address: 1941 Stryker Way, Portage, MI, United States, 49002
The CEO & director of Mr. Kevin A. Lobo. is Stryker Corporation (SYK), and CFO & Sr. VP is Mr. Kevin A. Lobo.
There is no promoter pledging in Stryker Corporation (SYK).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
22,494
|
|
|
17,245
|
|
|
16,488
|
|
|
14,088
|
| Stryker Corporation (SYK) | Ratios |
|---|---|
|
Return on equity(%)
|
15.26
|
|
Operating margin(%)
|
20.65
|
|
Net Margin(%)
|
13.25
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Stryker Corporation (SYK) was $2,993 Mln.
$8.99
(
